Switzerland· 55725060
Aranesp
A darbepoetin alfa product containing darbepoetinum alfa, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Darbepoetin alfa is registered in 14 of 19 countries.
Countries holding a registration under ATC B03XA02 (darbepoetin alfa), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 9 of them publish a price we can compare per daily dose
Darbepoetin alfa · ATC B03XA02
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of darbepoetin alfa costs, country by country.
Normalised to the WHO defined daily dose (4.5 mcg), so markets compare like for like.
- Switzerland: $12.85 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Darbepoetin alfa · price per daily dose (4.5 mcg)
USD · FX 28 Sept 2026
- CH Switzerland$12.85
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- darbepoetinum alfa
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- B03XA02
- ATC class
- Darbepoetin alfa
- Defined daily dose
- 4.5 mcg, P
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680557250603Fertspr 4 StkCHF 383.45
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
18 interactions on record for darbepoetin alfa.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Darbepoetin alfa · interactions on record
18 records
- 5 severe
- 3 moderate
- 10 minor
Most severe, free to view
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- ThalidomideL04AX02severe
- LenalidomideL04AX04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Darbepoetin alfa in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaARANESPAmgen Europe B.V., Breda
- SpainARANESP 40 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADAAmgen Europe B.V.
- SwedenAranesp 40 mikrogram Injektionsvätska, lösningAmgen Europe B.V.
- United KingdomAranesp 15micrograms/0.375ml solution for injection pre-filled syringesAmgen Ltd
- NorwayAranespAmgen Europe B.V.
- BelgiumAranesp 40 µgAmgen Europe
- IrelandAranesp 40 micrograms solution for injection in pre-filled penAmgen Europe B.V.,
- FinlandNespoDompé Biotec S.p.A
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Aranesp
- Norway · Aranesp
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0a292f4d-d62c-48b8-9f80-85b308a33ec9 GET /v1/drugs/0a292f4d-d62c-48b8-9f80-85b308a33ec9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "darbepoetinum alfa 0.04 mg",
"valid_from": "2002-11-01",
"limitations": "[{\"description\":\"<b>Renale Anämie bei Niereninsuffizienz: 17807.01</b><br>\\nFolgender Indikationscode ist an den Krankenversicherer zu übermitteln: 17807.01<br>\\n<br>\\n\",\"costApproval\":null,\"indication\":\"17807.01\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2022-04-01\",\"validTo\":null},{\"description\":\"Behandlung der <b>symptomatischen Anämie bei erwachsenen Tumorpatienten/innen</b> mit einem Hämoglobinwert von < 10.5 g/dl, bei welchen eine Chemotherapie über eine Mindestdauer von 2 Monaten vorgesehen ist: 17807.02<br>\\nFolgender Indikationscode ist an den Krankenversicherer zu übermitteln: 17807.02<br>\\n<br>\",\"costApproval\":null,\"indication\":\"17807.02\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2022-04-01\",\"validTo\":null}]",
"galenic_form": "Inj Lös 40 mcg m Nadelschutz",
"therapeutic_area": null,
"sl_inclusion_date": "2002-11-01",
"self_retention_pct": 10
}See everything about darbepoetin alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.